Mechanisms of myelopoiesis after myocardial infarction
心肌梗死后骨髓生成机制
基本信息
- 批准号:10415059
- 负责人:
- 金额:$ 47.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdoptive TransferApolipoprotein EApplications GrantsArterial Fatty StreakAtherosclerosisBinding SitesBiological AssayBloodBlood PlateletsBlood VesselsBone MarrowBone Marrow CellsBone Marrow TransplantationC57BL/6 MouseCardiac MyocytesCell CountCell Differentiation processCellsColorDataDiseaseDistantEventExposure toFlow CytometryGenerationsHMGB1 geneHeartHematopoietic stem cellsIn VitroInflammationInflammatoryInjuryInterleukin ReceptorInterleukin-3 ReceptorIschemiaKnockout MiceKnowledgeLocationLow Density Lipoprotein ReceptorLuciferasesMagnetic Resonance ImagingMeasuresMediatingMessenger RNAMethylcelluloseMicroRNAsMolecularMusMyelogenousMyeloid CellsMyelopoiesisMyocardial InfarctionOilsOrganPathogenesisPatientsProcessProductionProliferatingRoleSignal TransductionStainsTechnologyTestingTrichrome stain methodbasecytokinedrug developmentextracellular vesiclesfluorescence molecular tomographyhematopoietic differentiationimprovedin silicoin vivointravital microscopyischemic injurymigrationmouse modelnecdinnovel therapeuticsoverexpressionprogenitorreconstitutionsham surgerystem cell proliferationstem cellstranscription factorultrasound
项目摘要
Project Summary/ Abstract:
An acute injury, such as myocardial infarction (MI), induces exaggerated production of myeloid cells in the
bone marrow. These newly generated myeloid cells are inflammatory and are crucial in disease
pathogenesis, exacerbating underlying processes such as atherosclerosis. However, the systemic long
distance signals and molecular mechanisms that trigger myelopoiesis in the bone marrow after an ischemic
event at a distant organ, such as the heart, are poorly understood. Our preliminary data revealed that,
following an MI, bone marrow hematopoietic stem and progenitor cells (HSPC) relocated into the vascular
niches. Vascular niches confer distinct microenvironments promoting HSPC proliferation and differentiation.
In investigating the long-distance signals produced after MI, we found increased levels of platelet-derived
extracellular vesicles (pEV) in the blood of patients and mice after MI. These pEV increased the expression
of PU.1, which is a myeloid transcription factor, and the receptor for interleukin-3 (IL-3R), which increases
myeloid cell generation, in bone marrow HSPC. Additionally, pEV isolated from mice with MI contained high
levels of miR-499, which increased bone marrow HSPC proliferation and differentiation in vitro. From these
observations, we hypothesize that increased miR-499 in pEV following MI relocates HSPC to active
vascular niches in the bone marrow, where they proliferate and differentiate into myeloid cells. We will test
this hypothesis in two specific aims: (1) We will determine the role of pEV in relocation of HSPC to the
vascular niches in the bone marrow. (2) We will investigate if increased miR-499 expression in pEV
augments myelopoiesis and atherosclerosis after MI. To test the hypothesis, we will photoconvert KikGR+
HSPC, use mice deficient of miR-499 and two different mouse models of atherosclerosis. We will
characterize pEV in patients and mice with MI using flow cytometry, ImageStream and NanoSight
technologies. Additionally, we will determine the proliferation of HSPC exposed to pEV isolated from miR-
499+/+ and miR-499-/- mice after MI in vitro and in vivo. The proposed grant application will further our
understanding of the mechanisms of MI-induced myelopoiesis, and explore new therapeutic avenues to
diminish inflammation and atherosclerosis after MI.
项目摘要/摘要:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Partha Dutta其他文献
Partha Dutta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Partha Dutta', 18)}}的其他基金
The role of SerpinB2 in insulin resistance and inflammation
SerpinB2 在胰岛素抵抗和炎症中的作用
- 批准号:
10445110 - 财政年份:2022
- 资助金额:
$ 47.41万 - 项目类别:
The role of SerpinB2 in insulin resistance and inflammation
SerpinB2 在胰岛素抵抗和炎症中的作用
- 批准号:
10615780 - 财政年份:2022
- 资助金额:
$ 47.41万 - 项目类别:
The role of microglia Nek6 in myocardial infarction-induced cognitive impairment
小胶质细胞 Nek6 在心肌梗死所致认知障碍中的作用
- 批准号:
10713921 - 财政年份:2020
- 资助金额:
$ 47.41万 - 项目类别:
Mechanisms of myelopoiesis after myocardial infarction
心肌梗死后骨髓生成机制
- 批准号:
10625852 - 财政年份:2020
- 资助金额:
$ 47.41万 - 项目类别:
Mechanisms of myelopoiesis after myocardial infarction
心肌梗死后骨髓生成机制
- 批准号:
10171888 - 财政年份:2020
- 资助金额:
$ 47.41万 - 项目类别:
Mechanisms of Myocardial Infarction-induced insulin resistance
心肌梗死引起的胰岛素抵抗的机制
- 批准号:
10116453 - 财政年份:2018
- 资助金额:
$ 47.41万 - 项目类别:
Effect of diabetes on myelopoiesis and atherosclerosis
糖尿病对骨髓细胞生成和动脉粥样硬化的影响
- 批准号:
9172344 - 财政年份:2013
- 资助金额:
$ 47.41万 - 项目类别:
Effect of diabetes on myelopoiesis and atherosclerosis
糖尿病对骨髓细胞生成和动脉粥样硬化的影响
- 批准号:
8617386 - 财政年份:2013
- 资助金额:
$ 47.41万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 47.41万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 47.41万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 47.41万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 47.41万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 47.41万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 47.41万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 47.41万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 47.41万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 47.41万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 47.41万 - 项目类别:














{{item.name}}会员




